Marisa Cabrita

Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial

M. Feldmann, S. Lamb, S. Dutton, 2018, EBioMedicine.

Quantification of cell cycle kinetics by EdU (5-ethynyl-2′-deoxyuridine)-coupled-fluorescence-intensity analysis

A. Serra-Caetano, R. Santus, J. Rino, 2017, Oncotarget.

Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300

J. Knight, A. Cribbs, M. Feldmann, 2020, Proceedings of the National Academy of Sciences.

Cellular census of human fibrosis defines functionally distinct stromal cell types and states

S. Sansom, M. Feldmann, J. Nanchahal, 2020, Nature Communications.

Altered expression of CD1d molecules and lipid accumulation in the human hepatoma cell line HepG2 after iron loading

E. Cardoso, Fernando A. Arosa, P. Rodrigues, 2004, The FEBS journal.

Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis

M. Feldmann, A. I. Espírito Santo, J. Nanchahal, 2019, Science Advances.

Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states

Cameron P. Brown, M. Feldmann, J. Nanchahal, 2020, Biology Open.